MaxCyte to cut 34% of workforce in restructuring to reach profitability Sep 22, 2025 04:31PM
MaxCyte, Inc. (MXCT) Announces Departure of Chief Commercial Officer Aug 11, 2025 04:33PM
BTIG Downgrades MaxCyte Inc. (MXCT) to Neutral Aug 11, 2025 06:06AM
William Blair Downgrades MaxCyte Inc. (MXCT) to Market Perform Aug 7, 2025 04:02AM
MaxCyte, Inc. (MXCT) Misses Q2 EPS by 2c Aug 6, 2025 06:40PM


May 8, 2025 05:47AM MaxCyte Inc. (MXCT) PT Lowered to $5 at BTIG
May 7, 2025 04:54PM MaxCyte, Inc. (MXCT) Tops Q1 EPS by 1c
Mar 12, 2025 09:17AM MaxCyte Inc. (MXCT) PT Lowered to $9 at Stifel
Mar 12, 2025 05:29AM MaxCyte Inc. (MXCT) PT Lowered to $6 at BTIG
Mar 11, 2025 05:14PM MaxCyte, Inc. (MXCT) Tops Q4 EPS by 2c
Nov 6, 2024 05:05PM MaxCyte, Inc. (MXCT) Tops Q3 EPS by 1c
Oct 15, 2024 08:05AM Poseida Therapeutics (PSTX) Appoints Cynthia Collins to its Board
Sep 24, 2024 08:38AM TD Cowen Reiterates Buy Rating on MaxCyte Inc. (MXCT)